By adopting the perspective that cancer is a pathological ecosystem, we can better understand how Eph/ephrin-mediated interactions contribute to tumor heterogeneity, therapeutic resistance, and the evolutionary adaptation of oral and maxillofacial cancers. The gene discussed is EPHA1; the disease is neoplasm.